University of Utah

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).

818 total trials 138 currently recruiting 492 completed early-phase tilt top decile by trial count

University of Utah: 818 sponsored US clinical trials, 138 recruiting.

University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.

Top-decile sponsor footprint

University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 41/100

492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

818 total, page 8 of 17

TERMINATED NA

Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy

NCT04594057

TERMINATED Phase 2

Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

NCT04162873

TERMINATED NA

Peripheral Nerve Stimulation for Back

NCT04538430

COMPLETED NA

CROS and Quality of Life of Elderly Cochlear Implant Recipients and Their Care Givers

NCT04794179

TERMINATED NA

Acupuncture Treatment of Chemotherapy-Induced Peripheral Neuropathy in Women

NCT04067544

COMPLETED

Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool

NCT03936985

COMPLETED NA

Preoperative Psychosocial Support for Postoperative Recovery and Health: Mechanistic Substudy

NCT04520958

COMPLETED NA

C-RFA of Residual Limb Neuroma

NCT04538417

COMPLETED Early Phase 1

Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation

NCT04130061

COMPLETED NA

Risk Information and Skin-cancer Education for Undergraduate Prevention

NCT03979872

TERMINATED NA

Acupuncture Combined With Mindfulness: ACUMIND

NCT04089319

TERMINATED NA

Sacral Nerve Stimulation in Improving Bladder Function After Acute Traumatic Spinal Cord Injury

NCT03083366

COMPLETED NA

Home-based HIIT to Improve CRC Survivorship: Feasibility and Relationship With Novel Surrogate Biomarkers of CRC Recurrence

NCT04080414

COMPLETED Phase 4

A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery

NCT04015908

TERMINATED Early Phase 1

L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia

NCT03542812

COMPLETED Phase 2

Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma

NCT04066725

COMPLETED Early Phase 1

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

NCT03987217

TERMINATED NA

Prediabetes, Exercise, and Appetite Regulation

NCT04910763

COMPLETED NA

Self-management Intervention for Children With Chronic Medical Complexity: Pilot Feasibility Trial

NCT04470193

COMPLETED

Circadian Timing, Information Processing and Energy Balance Study

NCT04759755

TERMINATED Phase 2

Rucaparib in Nonmetastatic prOstAte With BRCAness

NCT03533946

TERMINATED Early Phase 1

CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia

NCT03972943

COMPLETED NA

Fatigue, Anxiety, Music, and Entertainment (FAME) Study

NCT03955003

TERMINATED Phase 2

Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors

NCT03627403

COMPLETED NA

Me & My Wishes: An Efficacy Trial Using Videos

NCT03861429

COMPLETED NA

Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population

NCT04570605

TERMINATED NA

Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants

NCT03558737

COMPLETED NA

Examining the Impact of Mindfulness on Patients' Experience of Osteopathic Manipulation

NCT04477278

COMPLETED NA

Optimize Low Back Pain

NCT03859713

COMPLETED NA

Suicide and Trauma Reduction Initiative Among VEterans

NCT03933059

COMPLETED NA

Vascular Dysfunction During Physical Inactivity

NCT04872998

COMPLETED NA

Optimizing Pregnancy and Treatment Interventions for Moms 2.0

NCT03833245

COMPLETED NA

Translational Control of Anabolic Resistance in Aging Muscle

NCT03839628

COMPLETED

Smart Autofocusing Eyeglasses

NCT03911596

TERMINATED

The Iron Content of Ferritin in Serum and Urine of Children With High Serum Ferritin Levels

NCT03777904

TERMINATED Phase 4

Intradiscal Platelet Rich Plasma

NCT04544709

TERMINATED Phase 2

Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

NCT03827473

COMPLETED NA

Perinatal Care and Medication Assisted Treatment: Carbon/Emery Counties

NCT04448015

TERMINATED NA

Influence of Opioid Use on the Effects of Spinal Manipulative Therapy for Low Back Pain

NCT03749564

COMPLETED NA

Randomized Experiment of Sleep Technology

NCT04246424

COMPLETED Phase 1

Hyperhidrosis in Patients With Amputations-Botox

NCT03236012

COMPLETED NA

Combining Flash Glucose Monitoring and Online Peer Support to Improve Outcomes in Hispanics With Type 2 Diabetes

NCT03799796

COMPLETED NA

Evaluation of a Dashboard for Diabetes Care Integrated With the Electronic Health Record

NCT03826290

TERMINATED NA

Program to Improve Dental Care: Children With ASD

NCT03546504

COMPLETED NA

Fearon Algorithm in Warfarin Patient Self-Management

NCT03911661

COMPLETED NA

Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care

NCT03780491

TERMINATED Early Phase 1

PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis

NCT03507374

COMPLETED Phase 4

Effectiveness of Cervical Transforaminal Epidural Steroid Injection

NCT04544683

COMPLETED Phase 2

Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone

NCT03707184

COMPLETED NA

A Prospective Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves Versus Facet Joint Injection of Corticosteroid for the Treatment of Lumbar Facet Syndrome

NCT03614793

← Previous Page 8 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 145
Phase 2 123
Phase 3 18
Phase 4 27

What is open in the University of Utah pipeline

138 recruiting of 818 indexed (17% open); 492 completed (60%).

Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).

Top condition: Low Back Pain (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Utah: open-pipeline peers nationwide

Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of UtahUniversity of Texas Southwestern Medical CenterUniversity of ChicagoDana-Farber Cancer InstituteUniversity of California, San DiegoUniversity of HawaiiPenn State UniversityAdventHealthCSL Behring
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 818 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this University of Utah page

818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.

  • 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Utah pipeline card: 818 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.